Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VINCA study of one-hour versus short vincristine infusions in children with cancer
2014-001561-27Phase 4Completed
- Sponsor
- VU university medical center
- Start
- Jun 2014
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of vincristine in acute lymphoblastic leukemia (ALL), Wilms' tumor, medulloblastoma and 3 more (2 arms), sponsored by VU university medical center. Primary endpoint: Peripheral neuropathy. Started Jun 2014; status: completed.
02
Drugs
vincristine
03
Conditions
acute lymphoblastic leukemia (ALL)Wilms' tumormedulloblastomagliomaHodgkin lymphoma (HL)
Beyond the preview
Go deeper on 2014-001561-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001561-27.